Behavioral health interventions for pediatric acute lymphoblastic leukemia: a scoping review. [PDF]
Bates CR +7 more
europepmc +1 more source
Cell‐MICS: Detecting Immune Cells With Label‐Free Two‐Photon Autofluorescence and Deep Learning
We demonstrate multiphoton imaging with computational specificity for label‐free cell identification (cell‐MICS). Based on the intrinsic contrast of two‐photon induced autofluorescence from metabolic proteins, a deep neural network is able to distinguish various different immune cell types. The system's performance is stable and efficient.
Lucas Kreiss +9 more
wiley +1 more source
Targeted therapies in pediatric B-Cell acute lymphoblastic leukemia: mechanisms, efficacy, and future directions. [PDF]
Correa-Carranza V +5 more
europepmc +1 more source
Abstract Background Chronic myeloid leukemia (CML) presenting in blast crisis (BC) is uncommon in the era of tyrosine kinase inhibitor (TKI) treatment, and T‐lymphoblastic BC is exceptionally rare. We report a case of T‐lymphoid BC presenting with extreme hyperleukocytosis.
E. Somasundaram +4 more
wiley +1 more source
Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemia. [PDF]
Lipshultz SE +3 more
europepmc +1 more source
Pediatric acute lymphoblastic leukemia relapse and prognosis: key predictors and therapeutic implications. [PDF]
Chen X +6 more
europepmc +1 more source
Acute lymphoblastic leukemia with bone marrow necrosis as the first clinical manifestation: a pediatric case report. [PDF]
Pan L +5 more
europepmc +1 more source
Diazinon may increase the risk of acute lymphoblastic leukemia by inducing <i>MGMT</i> promoter methylation. [PDF]
Rafeeinia A +5 more
europepmc +1 more source
A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia: Preliminary Results of the "ALL Urayasu Classification". [PDF]
Mitsumori T +13 more
europepmc +1 more source
Correction to "Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials". [PDF]
europepmc +1 more source

